{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T11:12:40Z","timestamp":1788606760145,"version":"build-2803163510"},"reference-count":104,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"36","license":[{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The authors are grateful to the Deanship of Graduate Studies and Scientific Research at Najran University for funding this work under the Easy Funding Program grant code","award":["NU\/EFP\/4588\/13\/25"],"award-info":[{"award-number":["NU\/EFP\/4588\/13\/25"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Systemic toxicity, poor drug selectivity, treatment resistance, and inconsistent tumor responses are some of the therapeutic issues related to thyroid cancer (TC). Chitosan-based nanoparticles (ChNPs) have shown promise as nanocarriers for target drug delivery due to their mucoadhesive qualities, biodegradability, biocompatibility, and simplicity of surface modification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>With an emphasis on their role in enhancing drug delivery and targeting efficiency, this review compiled the literature on recent developments in the design, functionalization, and use of ChNPs for TC therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>According to available data, physicochemical changes such as ligand conjugation, PEGylation, and stimuli-responsive linkers can support the stability, cellular uptake, circulation time, and therapeutic efficacy of NPs. ChNPs can deliver anticancer drugs to thyroid carcinoma cells with greater selectivity by utilizing both active targeting through ligand-mediated interactions and passive targeting through the increased permeability and retention effect. When compared to traditional therapeutic methods, preclinical research has shown better boosted antitumor activity, medication absorption, and dimensioned systemic toxicity. However, difficulties with large-scale production, regulatory approval, and long-term safety evaluation continue to hinder clinical translation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Although further translational and clinical research is required to confirm ChNPs\u2019 safety and efficacy in standard clinical practice, they offer a promising platform for targeted TC treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050490","type":"journal-article","created":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T11:00:10Z","timestamp":1788606010000},"page":"e50490","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Chitosan-based nanoparticles as a targeted drug delivery system to treat thyroid cancer"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3513-4976","authenticated-orcid":false,"given":"Hamad S.","family":"Alyami","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics, College of Pharmacy, Najran University, Najran, Saudi Arabia"},{"name":"Health Research Center, Najran University, Najran, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora A.","family":"Ahmadi","sequence":"additional","affiliation":[{"name":"Department of Chemistry, College of Science and Arts, Najran University, Najran, Saudi Arabia"},{"name":"Creativity in Development School, Najran Education Administration, Najran, Saudi Arabia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-20260905","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1097\/CM9.0000000000003284","article-title":"Global burden of thyroid cancer in 2022: incidence and mortality estimates from GLOBOCAN.","volume":"137","author":"Lyu","year":"2024","journal-title":"Chin Med J (Engl)"},{"key":"R3-20260905","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R4-20260905","doi-asserted-by":"crossref","first-page":"e0318605","DOI":"10.1371\/journal.pone.0318605","article-title":"Global burden of thyroid cancer in adolescents and young adults (aged 15\u201339 years) from 1990 to 2021: a systematic analysis of the global burden of disease study 2021.","volume":"20","author":"Qiu","year":"2025","journal-title":"PLoS One"},{"key":"R5-20260905","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/CEJ.0000000000000983","article-title":"Thyroid cancer in Asia: incidence, mortality in 2022, and future projections to 2050.","volume":"35","author":"Fu","year":"2026","journal-title":"Eur J Cancer Prev"},{"key":"R6-20260905","doi-asserted-by":"crossref","first-page":"699805","DOI":"10.3389\/fendo.2021.699805","article-title":"Recent trends in surgical approach to thyroid cancer.","volume":"12","author":"Rossi","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R7-20260905","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1002\/cncr.33804","article-title":"Intensity-modulated radiation therapy and doxorubicin in thyroid cancer: a prospective phase 2 trial.","volume":"127","author":"Romesser","year":"2021","journal-title":"Cancer"},{"key":"R8-20260905","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/21691401.2021.1871620","article-title":"Selenium nanoparticles coated with pH responsive silk fibroin complex for fingolimod release and enhanced targeting in thyroid cancer.","volume":"49","author":"Zou","year":"2021","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"R9-20260905","doi-asserted-by":"crossref","first-page":"236","DOI":"10.14639\/0392-100X-N1412","article-title":"Predictive factors for recurrence of papillary thyroid carcinoma: analysis of 4,085 patients.","volume":"41","author":"Ywata de Carvalho","year":"2021","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"R10-20260905","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.3390\/nu14061298","article-title":"Nutrition in advanced thyroid cancer patients.","volume":"14","author":"Agate","year":"2022","journal-title":"Nutrients"},{"key":"R11-20260905","doi-asserted-by":"crossref","first-page":"9989757","DOI":"10.1155\/2021\/9989757","article-title":"Recurrence factors and characteristic trends of papillary thyroid cancer over three decades.","volume":"2021","author":"Chatchomchuan","year":"2021","journal-title":"Int J Endocrinol"},{"key":"R12-20260905","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.3390\/ijms23073470","article-title":"State of the art in the current management and future directions of targeted therapy for differentiated thyroid cancer.","volume":"23","author":"Silaghi","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R13-20260905","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1089\/thy.2022.0704","article-title":"Challenges and strategies to combat resistance mechanisms in thyroid cancer therapeutics.","volume":"33","author":"Gild","year":"2023","journal-title":"Thyroid"},{"key":"R14-20260905","doi-asserted-by":"crossref","first-page":"188928","DOI":"10.1016\/j.bbcan.2023.188928","article-title":"Molecular basis and targeted therapy in thyroid cancer: progress and opportunities.","volume":"1878","author":"Zhang","year":"2023","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"R15-20260905","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1186\/s12885-021-08257-x","article-title":"Efficacy and safety of peptide receptor radionuclide therapy in advanced radioiodine-refractory differentiated thyroid cancer and metastatic medullary thyroid cancer: a systematic review.","volume":"21","author":"Maghsoomi","year":"2021","journal-title":"BMC Cancer"},{"key":"R16-20260905","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/iub.2601","article-title":"Evaluating the therapeutic efficacy of radiolabeled BSA@CuS nanoparticle-induced radio-photothermal therapy against anaplastic thyroid cancer.","volume":"74","author":"Zhang","year":"2022","journal-title":"IUBMB Life"},{"key":"R17-20260905","doi-asserted-by":"crossref","first-page":"1372553","DOI":"10.3389\/fendo.2024.1372553","article-title":"Advances in targeted therapy and biomarker research in thyroid cancer.","volume":"15","author":"Guo","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R18-20260905","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.3390\/cancers13164063","article-title":"Nanoparticles: promising auxiliary agents for diagnosis and therapy of thyroid cancers.","volume":"13","author":"Fr\u00f6hlich","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R19-20260905","doi-asserted-by":"crossref","first-page":"124345","DOI":"10.1016\/j.ijpharm.2024.124345","article-title":"Nanotechnology in medicine revolutionizing drug delivery for cancer and viral infection treatments.","volume":"660","author":"Karahmet Sher","year":"2024","journal-title":"Int J Pharm"},{"key":"R20-20260905","doi-asserted-by":"crossref","first-page":"13257","DOI":"10.1021\/acsnano.2c08675","article-title":"What do we mean when we say nanomedicine?","volume":"16","author":"Liz-Marz\u00e1n","year":"2022","journal-title":"ACS Nano"},{"key":"R21-20260905","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41392-023-01536-y","article-title":"Nanomedicine in cancer therapy.","volume":"8","author":"Fan","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"R22-20260905","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.3390\/app15063189","article-title":"Enhancement of EPR effect for passive tumor targeting: current status and future perspectives.","volume":"15","author":"Vagena","year":"2025","journal-title":"Applied Sciences"},{"key":"R23-20260905","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3390\/jpm13030389","article-title":"Approaches to improve EPR-based drug delivery for cancer therapy and diagnosis.","volume":"13","author":"Subhan","year":"2023","journal-title":"J Pers Med"},{"key":"R24-20260905","doi-asserted-by":"crossref","first-page":"8606","DOI":"10.1039\/D2RA07863E","article-title":"Cancer nanomedicine: a review of nano-therapeutics and challenges ahead.","volume":"13","author":"Nirmala","year":"2023","journal-title":"RSC Adv"},{"key":"R25-20260905","doi-asserted-by":"crossref","first-page":"5145","DOI":"10.3390\/molecules28135145","article-title":"Cancer nanomedicine: emerging strategies and therapeutic potentials.","volume":"28","author":"Xu","year":"2023","journal-title":"Molecules"},{"key":"R26-20260905","doi-asserted-by":"crossref","first-page":"3687700","DOI":"10.1155\/2021\/3687700","article-title":"Paclitaxel: application in modern oncology and nanomedicine-based cancer therapy.","volume":"2021","author":"Sharifi-Rad","year":"2021","journal-title":"Oxid Med Cell Longev"},{"key":"R27-20260905","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/s12951-023-02094-9","article-title":"Customizing cancer treatment at the nanoscale: a focus on anaplastic thyroid cancer therapy.","volume":"21","author":"Wang","year":"2023","journal-title":"J Nanobiotechnol"},{"key":"R28-20260905","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3390\/jfb13040196","article-title":"Overview of physicochemical properties of nanoparticles as drug carriers for targeted cancer therapy.","volume":"13","author":"Yagublu","year":"2022","journal-title":"J Funct Biomater"},{"key":"R29-20260905","doi-asserted-by":"crossref","first-page":"e2203325","DOI":"10.1002\/adma.202203325","article-title":"Nanochitin and nanochitosan: chitin nanostructure engineering with multiscale properties for biomedical and environmental applications.","volume":"35","author":"Lee","year":"2023","journal-title":"Adv Mater"},{"key":"R30-20260905","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.3390\/polym14193989","article-title":"Chitin, chitosan, and nanochitin: extraction, synthesis, and applications.","volume":"14","author":"Kozma","year":"2022","journal-title":"Polymers (Basel)"},{"key":"R31-20260905","doi-asserted-by":"crossref","first-page":"675","DOI":"10.3390\/md20110675","article-title":"A review of the chemical extraction of chitosan from shrimp wastes and prediction of factors affecting chitosan yield by using an artificial neural network.","volume":"20","author":"Hosney","year":"2022","journal-title":"Mar Drugs"},{"key":"R32-20260905","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jobab.2022.01.002","article-title":"Sources, production and commercial applications of fungal chitosan: a review.","volume":"7","author":"Huq","year":"2022","journal-title":"J Bioresources Bioproducts"},{"key":"R33-20260905","doi-asserted-by":"crossref","first-page":"29139","DOI":"10.1021\/acsomega.3c10102","article-title":"Hydrogel encapsulation techniques and its clinical applications in drug delivery and regenerative medicine: a systematic review.","volume":"9","author":"Farasati Far","year":"2024","journal-title":"ACS Omega"},{"key":"R34-20260905","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3390\/gels9050398","article-title":"Biocompatible glycol chitosan microgels as effective drug carriers.","volume":"9","author":"Sahiner","year":"2023","journal-title":"Gels"},{"key":"R35-20260905","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.3390\/polym13111717","article-title":"Chitosan-based nanoparticles of targeted drug delivery system in breast cancer treatment.","volume":"13","author":"Herdiana","year":"2021","journal-title":"Polymers (Basel)"},{"key":"R36-20260905","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.3390\/polym13152514","article-title":"Biomedical applications of quaternized chitosan.","volume":"13","author":"Pathak","year":"2021","journal-title":"Polymers (Basel)"},{"key":"R37-20260905","doi-asserted-by":"crossref","first-page":"9652","DOI":"10.3390\/ijms22179652","article-title":"Advances in chitosan-based nanoparticles for drug delivery.","volume":"22","author":"Miku\u0161ov\u00e1","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R38-20260905","doi-asserted-by":"crossref","first-page":"125801","DOI":"10.1016\/j.ijbiomac.2023.125801","article-title":"Injectable multifunctional carboxymethyl chitosan\/hyaluronic acid hydrogel for drug delivery systems.","volume":"249","author":"Zhang","year":"2023","journal-title":"Int J Biol Macromol"},{"key":"R39-20260905","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.3390\/molecules29102393","article-title":"Recent advancements in metallic Au- and Ag-based chitosan nanocomposite derivatives for enhanced anticancer drug delivery.","volume":"29","author":"El-Meligy","year":"2024","journal-title":"Molecules"},{"key":"R40-20260905","first-page":"1","article-title":"Impact of deacetylation degree on properties of chitosan for formation of electrosprayed nanoparticles.","volume":"2022","author":"Nguyen","year":"2022","journal-title":"J Nanotechnol"},{"key":"R41-20260905","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3390\/md20050278","article-title":"Preparation of doxorubicin-loaded carboxymethyl-\u03b2-cyclodextrin\/chitosan nanoparticles with antioxidant, antitumor activities and pH-sensitive release.","volume":"20","author":"Mi","year":"2022","journal-title":"Mar Drugs"},{"key":"R42-20260905","doi-asserted-by":"crossref","first-page":"124876","DOI":"10.1016\/j.ijbiomac.2023.124876","article-title":"Impact of molecular weight and deacetylation degree of chitosan on the bioaccessibility of quercetin encapsulated in alginate\/chitosan-coated zein nanoparticles.","volume":"242","author":"Carrasco-Sandoval","year":"2023","journal-title":"Int J Biol Macromol"},{"key":"R43-20260905","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.3390\/polym13071027","article-title":"Recent advancements in polymer\/liposome assembly for drug delivery: from surface modifications to hybrid vesicles.","volume":"13","author":"De Leo","year":"2021","journal-title":"Polymers (Basel)"},{"key":"R44-20260905","doi-asserted-by":"crossref","first-page":"18754","DOI":"10.1038\/s41598-024-69438-9","article-title":"Synthesis, characterization of chitosan\/tripolyphosphate nanoparticles loaded with 4-chloro-2-methylphenoxyacetate sodium salt and its herbicidal activity against Bidens pilosa L.","volume":"14","author":"Jiang","year":"2024","journal-title":"Sci Rep"},{"key":"R45-20260905","doi-asserted-by":"crossref","first-page":"104849","DOI":"10.1016\/j.reactfunctpolym.2021.104849","article-title":"Preparation methods and applications of chitosan nanoparticles; with an outlook toward reinforcement of biodegradable packaging.","volume":"161","author":"Yanat","year":"2021","journal-title":"React Funct Polym"},{"key":"R46-20260905","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3390\/gels10030189","article-title":"Spray-dried chitosan hydrogel particles as a potential delivery system for benzydamine hydrochloride.","volume":"10","author":"Milenkova","year":"2024","journal-title":"Gels"},{"key":"R47-20260905","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/s41598-020-58184-3","article-title":"Investigations of the influences of processing conditions on the properties of spray dried chitosan-tripolyphosphate particles loaded with theophylline.","volume":"10","author":"Wei","year":"2020","journal-title":"Sci Rep"},{"key":"R48-20260905","doi-asserted-by":"crossref","first-page":"159781","DOI":"10.1016\/j.cej.2025.159781","article-title":"Microfluidic production of chitosan nanoparticles via Ouzo effect.","volume":"506","author":"Masoni","year":"2025","journal-title":"Chem Eng J"},{"key":"R49-20260905","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.2174\/1389450121666200711172536","article-title":"Chitosan nanoparticles as a novel drug delivery system: a review article.","volume":"21","author":"Matalqah","year":"2020","journal-title":"Curr Drug Targets"},{"key":"R50-20260905","doi-asserted-by":"crossref","first-page":"118027","DOI":"10.1016\/j.carbpol.2021.118027","article-title":"Microfluidic platform for synthesis and optimization of chitosan-coated magnetic nanoparticles in cisplatin delivery.","volume":"265","author":"Siavashy","year":"2021","journal-title":"Carbohydr Polym"},{"key":"R51-20260905","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jsps.2016.12.008","article-title":"Effect of cryoprotection on particle size stability and preservation of chitosan nanoparticles with and without hyaluronate or alginate coating.","volume":"25","author":"Almalik","year":"2017","journal-title":"Saudi Pharm J"},{"key":"R52-20260905","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.3390\/nano15161276","article-title":"Green synthesis of chitosan-coated selenium nanoparticles for paclitaxel delivery.","volume":"15","author":"Al-Darwesh","year":"2025","journal-title":"Nanomaterials (Basel)"},{"key":"R53-20260905","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.3390\/app13031900","article-title":"Chitosan nanoparticles production: optimization of physical parameters, biochemical characterization, and stability upon storage.","volume":"13","author":"Costa","year":"2023","journal-title":"Appl Sci"},{"key":"R54-20260905","doi-asserted-by":"crossref","first-page":"1469271","DOI":"10.3389\/fchem.2024.1469271","article-title":"Synthesis of chitosan nanoparticles (CSNP): effect of CH\u2013CH\u2013TPP ratio on size and stability of NPs.","volume":"12","author":"Des Bouillons-Gamboa","year":"2024","journal-title":"Front Chem"},{"key":"R55-20260905","doi-asserted-by":"crossref","first-page":"5354","DOI":"10.1039\/D3MH00717K","article-title":"Dynamic light scattering and transmission electron microscopy in drug delivery: a roadmap for correct characterization of nanoparticles and interpretation of results.","volume":"10","author":"Filippov","year":"2023","journal-title":"Mater Horiz"},{"key":"R57-20260905","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.3390\/molecules28041963","article-title":"Chitosan-based nanoparticles as effective drug delivery systems-a review.","volume":"28","author":"Jafernik","year":"2023","journal-title":"Molecules"},{"key":"R58-20260905","doi-asserted-by":"crossref","first-page":"8373","DOI":"10.2147\/IJN.S472433","article-title":"Chitosan nanoparticles for targeted cancer therapy: a review of stimuli-responsive, passive, and active targeting strategies.","volume":"19","author":"Al-Shadidi","year":"2024","journal-title":"Int J Nanomedicine"},{"key":"R59-20260905","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.3390\/pharmaceutics16081043","article-title":"Drug loading in chitosan-based nanoparticles.","volume":"16","author":"Herdiana","year":"2024","journal-title":"Pharmaceutics"},{"key":"R60-20260905","doi-asserted-by":"crossref","first-page":"146514","DOI":"10.1016\/j.ijbiomac.2025.146514","article-title":"Overcoming stealthing effect of PEGylation on chitosan nanoparticles: optimization, characterization, and assessment of cytotoxicity, apoptosis, cellular internalization, and antimetastatic efficacy.","volume":"321","author":"Hussain","year":"2025","journal-title":"Int J Biol Macromol"},{"key":"R61-20260905","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1080\/10717544.2022.2089296","article-title":"Functional ligands for improving anticancer drug therapy: current status and applications to drug delivery systems.","volume":"29","author":"Bajracharya","year":"2022","journal-title":"Drug Deliv"},{"key":"R62-20260905","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3390\/nano15030158","article-title":"Surface functionalization of nanocarriers with anti-EGFR ligands for cancer active targeting.","volume":"15","author":"Spada","year":"2025","journal-title":"Nanomaterials (Basel)"},{"key":"R63-20260905","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.3390\/biomedicines12071393","article-title":"Rational design of pectin-chitosan polyelectrolyte nanoparticles for enhanced temozolomide delivery in brain tumor therapy.","volume":"12","author":"Silant\u2019ev","year":"2024","journal-title":"Biomedicines"},{"key":"R64-20260905","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3390\/molecules26020272","article-title":"Chitosan nanoparticles-insight into properties, functionalization and applications in drug delivery and theranostics.","volume":"26","author":"Jhaveri","year":"2021","journal-title":"Molecules"},{"key":"R65-20260905","doi-asserted-by":"crossref","first-page":"734","DOI":"10.3390\/nano11030734","article-title":"A cost-effective nano-sized curcumin delivery system with high drug loading capacity prepared via flash nanoprecipitation.","volume":"11","author":"Chen","year":"2021","journal-title":"Nanomaterials (Basel)"},{"key":"R66-20260905","doi-asserted-by":"crossref","first-page":"51379","DOI":"10.1021\/acsomega.4c08258","article-title":"Chitosan nanoparticles, a novel drug delivery system to transfer squalene for hepatocyte stress protection.","volume":"9","author":"Bidooki","year":"2024","journal-title":"ACS Omega"},{"key":"R67-20260905","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1208\/s12249-025-03100-z","article-title":"Chitosan nanoparticles: approaches to preparation, key properties, drug delivery systems, and developments in therapeutic efficacy.","volume":"26","author":"Obeidat","year":"2025","journal-title":"AAPS PharmSciTech"},{"key":"R68-20260905","doi-asserted-by":"crossref","first-page":"7544","DOI":"10.1039\/D3TB01175E","article-title":"Nanomaterials: a promising multimodal theranostics platform for thyroid cancer.","volume":"11","author":"Li","year":"2023","journal-title":"J Mater Chem B"},{"key":"R69-20260905","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s12672-024-01677-8","article-title":"Nanomedicine mediated thyroid cancer diagnosis and treatment: an approach from generalized to personalized medicine.","volume":"15","author":"Gulwani","year":"2024","journal-title":"Discov Oncol"},{"key":"R70-20260905","doi-asserted-by":"crossref","first-page":"1369780","DOI":"10.3389\/fimmu.2024.1369780","article-title":"Emerging therapeutic options for follicular-derived thyroid cancer in the era of immunotherapy.","volume":"15","author":"Turner","year":"2024","journal-title":"Front Immunol"},{"key":"R71-20260905","doi-asserted-by":"crossref","first-page":"2403170","DOI":"10.1080\/21645515.2024.2403170","article-title":"Emerging insights into thyroid cancer from immunotherapy perspective: a bibliometric analysis.","volume":"20","author":"Wang","year":"2024","journal-title":"Hum Vaccin Immunother"},{"key":"R72-20260905","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.2147\/IJN.S504503","article-title":"Extensive review of nanomedicine strategies targeting the tumor microenvironment in PDAC.","volume":"20","author":"Liu","year":"2025","journal-title":"Int J Nanomedicine"},{"key":"R73-20260905","doi-asserted-by":"crossref","first-page":"746","DOI":"10.3390\/ph18050746","article-title":"Harnessing the power of nanocarriers to exploit the tumor microenvironment for enhanced cancer therapy.","volume":"18","author":"Aldhubiab","year":"2025","journal-title":"Pharmaceuticals (Basel)"},{"key":"R74-20260905","doi-asserted-by":"crossref","first-page":"102385","DOI":"10.1016\/j.mtbio.2025.102385","article-title":"Multifunctional nanoplatforms for tumor microenvironment remodeling: toward precision and intelligent cancer therapy.","volume":"35","author":"Deng","year":"2025","journal-title":"Mater Today Bio"},{"key":"R75-20260905","doi-asserted-by":"crossref","first-page":"e1901223","DOI":"10.1002\/adhm.201901223","article-title":"Size-dependent EPR effect of polymeric nanoparticles on tumor targeting.","volume":"9","author":"Kang","year":"2020","journal-title":"Adv Healthc Mater"},{"key":"R76-20260905","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jconrel.2022.03.043","article-title":"Strategies to improve the EPR effect: a mechanistic perspective and clinical translation.","volume":"345","author":"Ikeda-Imafuku","year":"2022","journal-title":"J Control Release"},{"key":"R77-20260905","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jconrel.2022.04.025","article-title":"Changeable net charge on nanoparticles facilitates intratumor accumulation and penetration.","volume":"346","author":"Awaad","year":"2022","journal-title":"J Control Release"},{"key":"R78-20260905","doi-asserted-by":"crossref","first-page":"e240369","DOI":"10.1530\/ETJ-24-0369","article-title":"TSHR in thyroid cancer: bridging biological insights to targeted strategies.","volume":"14","author":"Xu","year":"2025","journal-title":"Eur Thyroid J"},{"key":"R79-20260905","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3390\/receptors3030016","article-title":"Receptor-targeted nanomedicine for cancer therapy.","volume":"3","author":"Prajapati","year":"2024","journal-title":"Receptors"},{"key":"R80-20260905","doi-asserted-by":"crossref","first-page":"125931","DOI":"10.1016\/j.ijpharm.2025.125931","article-title":"Breaking barriers with pH-responsive nanocarriers: a new frontier in precision oncology.","volume":"682","author":"Tapponi","year":"2025","journal-title":"Int J Pharm"},{"key":"R81-20260905","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41565-021-00858-8","article-title":"Key principles and methods for studying the endocytosis of biological and nanoparticle therapeutics.","volume":"16","author":"Rennick","year":"2021","journal-title":"Nat Nanotechnol"},{"key":"R82-20260905","doi-asserted-by":"crossref","first-page":"830","DOI":"10.3803\/EnM.2022.1636","article-title":"Preclinical models of follicular cell-derived thyroid cancer: an overview from cancer cell lines to mouse models.","volume":"37","author":"Jeon","year":"2022","journal-title":"Endocrinol Metab (Seoul)"},{"key":"R83-20260905","doi-asserted-by":"crossref","first-page":"e4652","DOI":"10.1210\/clinem\/dgab453","article-title":"Novel anaplastic thyroid cancer PDXs and cell lines: expanding preclinical models of genetic diversity.","volume":"106","author":"Maniakas","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"R84-20260905","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s12032-020-1345-2","article-title":"Preclinical and clinical combination therapies in the treatment of anaplastic thyroid cancer.","volume":"37","author":"Gentile","year":"2020","journal-title":"Med Oncol"},{"key":"R85-20260905","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/molecules29010031","article-title":"Optimized DOX drug deliveries via chitosan-mediated nanoparticles and stimuli responses in cancer chemotherapy: a review.","volume":"29","author":"Imran","year":"2023","journal-title":"Molecules"},{"key":"R86-20260905","doi-asserted-by":"crossref","first-page":"e10325","DOI":"10.1002\/btm2.10325","article-title":"Chitosan\u2010based nanoscale systems for doxorubicin delivery: exploring biomedical application in cancer therapy.","volume":"8","author":"Ashrafizadeh","year":"2022","journal-title":"Bioeng Transl Med"},{"key":"R87-20260905","doi-asserted-by":"crossref","first-page":"1043939","DOI":"10.3389\/fbioe.2022.1043939","article-title":"Temperature- and pH-responsive injectable chitosan hydrogels loaded with doxorubicin and curcumin as long-lasting release platforms for the treatment of solid tumors.","volume":"10","author":"Li","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"R88-20260905","doi-asserted-by":"crossref","first-page":"103851","DOI":"10.1016\/j.drudis.2023.103851","article-title":"Chitosan-functionalized bioplatforms and hydrogels in breast cancer: immunotherapy, phototherapy and clinical perspectives.","volume":"29","author":"Li","year":"2024","journal-title":"Drug Discov Today"},{"key":"R89-20260905","doi-asserted-by":"crossref","first-page":"22657","DOI":"10.1038\/s41598-025-07996-2","article-title":"Exploring the synergistic effects of metformin and doxorubicin loaded chitosan nanoparticles for A549 lung cancer therapy.","volume":"15","author":"Nazemiyeh","year":"2025","journal-title":"Sci Rep"},{"key":"R90-20260905","doi-asserted-by":"crossref","first-page":"17384","DOI":"10.1039\/D3RA02115G","article-title":"Comparison of bovine serum albumin and chitosan effects on calcium phosphate formation in the presence of silver nanoparticles.","volume":"13","author":"Inkret","year":"2023","journal-title":"RSC Adv"},{"key":"R91-20260905","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1080\/10717544.2022.2058648","article-title":"Chitosan-coated bovine serum albumin nanoparticles for topical tetrandrine delivery in glaucoma: in vitro and in vivo assessment.","volume":"29","author":"Radwan","year":"2022","journal-title":"Drug Deliv"},{"key":"R92-20260905","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.3390\/polym17111453","article-title":"Chitosan nanoparticle-based drug delivery systems: advances, challenges, and future perspectives.","volume":"17","author":"Stefanache","year":"2025","journal-title":"Polymers (Basel)"},{"key":"R93-20260905","doi-asserted-by":"crossref","first-page":"118999","DOI":"10.1016\/j.carbpol.2021.118999","article-title":"Analysis of clinical trials on biomaterial and therapeutic applications of chitosan: a review.","volume":"278","author":"Kantak","year":"2022","journal-title":"Carbohydr Polym"},{"key":"R94-20260905","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3390\/nano15020126","article-title":"Chitosan and its nanoparticles: a multifaceted approach to antibacterial applications.","volume":"15","author":"Akda\u015f\u00e7i","year":"2025","journal-title":"Nanomaterials (Basel)"},{"key":"R95-20260905","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2024.04.010","article-title":"Regulatory insights into nanomedicine and gene vaccine innovation: safety assessment, challenges, and regulatory perspectives.","volume":"180","author":"Souto","year":"2024","journal-title":"Acta Biomater"},{"key":"R96-20260905","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3390\/eng6070149","article-title":"Towards sustainable scaling-up of nanomaterials fabrication: current situation, challenges, and future perspectives.","volume":"6","author":"Hachhach","year":"2025","journal-title":"Eng"},{"key":"R97-20260905","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12951-023-01824-3","article-title":"In vivo toxicity evaluation of tumor targeted glycol chitosan nanoparticles in healthy mice: repeated high-dose of glycol chitosan nanoparticles potentially induce cardiotoxicity.","volume":"21","author":"Chang","year":"2023","journal-title":"J Nanobiotechnol"},{"key":"R98-20260905","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.actbio.2017.09.016","article-title":"Pro-inflammatory chitosan\/poly(\u03b3-glutamic acid) nanoparticles modulate human antigen-presenting cells phenotype and revert their pro-invasive capacity.","volume":"63","author":"Castro","year":"2017","journal-title":"Acta Biomater"},{"key":"R99-20260905","doi-asserted-by":"crossref","first-page":"e767","DOI":"10.1002\/mco2.767","article-title":"Nanomedicine for cancer patient-centered care.","volume":"5","author":"Sorrentino","year":"2024","journal-title":"MedComm (2020)"},{"key":"R100-20260905","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1186\/s12967-024-05490-3","article-title":"Hydrogel-based platforms for site-specific doxorubicin release in cancer therapy.","volume":"22","author":"Zang","year":"2024","journal-title":"J Transl Med"},{"key":"R101-20260905","doi-asserted-by":"crossref","first-page":"1329311","DOI":"10.3389\/fbioe.2023.1329311","article-title":"Smart nanogels for cancer treatment from the perspective of functional groups.","volume":"11","author":"Yu","year":"2023","journal-title":"Front Bioeng Biotechnol"},{"key":"R102-20260905","doi-asserted-by":"crossref","first-page":"105279","DOI":"10.1016\/j.jddst.2023.105279","article-title":"Evaluation of the theranostic characteristics of chitosan-decorated bismuth oxide nanoparticles conjugated curcumin and 5-aminolevulinic acid as a biocompatible targeted nanoplatform in CT and breast cancer radiation therapy.","volume":"92","author":"Dastgir","year":"2024","journal-title":"J Drug Delivery Sci Technol"},{"key":"R103-20260905","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1021\/acsbiomaterials.1c01631","article-title":"Polysaccharide-based theranostic systems for combined imaging and cancer therapy: recent advances and challenges.","volume":"8","author":"Gupta","year":"2022","journal-title":"ACS Biomater Sci Eng"},{"key":"R104-20260905","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1208\/s12249-023-02609-5","article-title":"Integrating artificial intelligence with quality by design in the formulation of lecithin\/chitosan nanoparticles of a poorly water-soluble drug.","volume":"24","author":"Dawoud","year":"2023","journal-title":"AAPS PharmSciTech"},{"key":"R105-20260905","first-page":"0016","article-title":"Artificial intelligence and machine learning implemented drug delivery systems: a paradigm shift in the pharmaceutical industry.","volume":"7","author":"Jena","year":"2024","journal-title":"J Bio-X Res"},{"key":"R106-20260905","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1186\/s12935-021-02025-4","article-title":"Chitosan nanoparticles as a promising tool in nanomedicine with particular emphasis on oncological treatment.","volume":"21","author":"Sharifi-Rad","year":"2021","journal-title":"Cancer Cell Int"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050490","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T11:00:23Z","timestamp":1788606023000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050490"}},"subtitle":["A literature review"],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":104,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050490","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,4]]},"assertion":[{"value":"2025-12-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}